Is it necessary to perform prospective randomized studies before sentinel node biopsy can replace routine axillary dissection?
- 1 July 2003
- journal article
- review article
- Published by Springer Nature in Breast Cancer
- Vol. 10 (3) , 179-187
- https://doi.org/10.1007/bf02966716
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissectionBritish Journal of Surgery, 2001
- Systemic treatment after sentinel lymph node biopsy in breast cancer: who, what, and why?Journal of the American College of Surgeons, 2001
- Credentialing for Breast Lymphatic Mapping: How Many Cases Are Enough?Annals of Surgery, 1999
- Sentinel-Lymph-Node Biopsy for Breast Cancer — Not Yet the Standard of CareNew England Journal of Medicine, 1998
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyNew England Journal of Medicine, 1998
- Diagnosis of axillary lymph node metastases in patients with breast cancerBreast Cancer Research and Treatment, 1996
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurgical Oncology, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985